Xu, R., He, X., Wufuli, R., Su, Y., Ma, L., Chen, R., . . . Liu, J. (2019). Choice of Capecitabine or S1 in Combination with Oxaliplatin based on Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase Expression Status in Patients with Advanced Gastric Cancer. J Gastric Cancer.
Citação norma ChicagoXu, Rong, Xiaolei He, Reyina Wufuli, Ying Su, Lili Ma, Ru Chen, Zhongcheng Han, Fang Wang, and Jiang Liu. "Choice of Capecitabine or S1 in Combination With Oxaliplatin Based On Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase Expression Status in Patients With Advanced Gastric Cancer." J Gastric Cancer 2019.
Citação norma MLAXu, Rong, et al. "Choice of Capecitabine or S1 in Combination With Oxaliplatin Based On Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase Expression Status in Patients With Advanced Gastric Cancer." J Gastric Cancer 2019.